Background Whereas much information exists in general oncology regarding the barriers to
clinical trial referral, those specific to neuro-oncology are not yet well known. Trial barriers …

Building on an initiative to enhance clinical trial participation involving the Society for Neuro-
Oncology, the Response Assessment in Neuro-Oncology Working Group, patient advocacy …

Purpose There is a lack of evidence regarding how patients with malignant brain tumor and
their relatives experience participation in neurooncological clinical trials. Similarly, insights …

Clinical trial accrual is vital to advancing care. A single study elucidated demographic data
correlating with glioma patients' clinical trial enrollment. However, it did not investigate the …

Importance While an overwhelming majority of patients diagnosed with cancer express
willingness to participate in clinical trials, only a fraction will enroll onto a research protocol …

Purpose: Realizing that education and awareness are paramount in making clinical trials
available to improve overall accrual rates, we sought to create a clinical trial navigation …

Results Telephone-based focus groups were conducted with four neurological disorder
patient groups (n= 22) and one caregiver group (n= 6). A total of 14 neurologists and …

Background Clinical trials are important to close the gap between therapeutic unmet needs
and scientific advances in neuro-oncology. This study analyzes the landscape of neuro …

We aimed to test any association between authors' conclusions and self-reported COI or
funding sources in central nervous system (CNS) studies. A review was performed for CNS …

Introduction Clinical trials, although academically accepted as the most effective treatment
available for cancer patients, poor accrual to clinical trials remains a significant problem. A …